Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC YC W21 teen and young adult investing education app at $3.5M ARR with 2M users and 10M+ lessons; $4.4M seed with 60+ modules and fractional stock/ETF/crypto trading competing with Greenlight and Acorns for Gen Z financial literacy and first investing.
Bloom is a New York-based investing education and fractional trading app for teenagers and young adults — backed by Y Combinator (W21) with $4.4 million in total funding including $3.3 million from investors in 2022 — providing users aged 13-17 and young adults with commission-free fractional trading in stocks, ETFs, and crypto combined with 60+ structured financial education modules and a gamified learning experience that has delivered over 10 million lessons since launching in April 2022, achieving $3.5 million ARR with 2 million users. Founded in 2021 by Allan Maman, Sonny Mo, and Sam Yang, Bloom serves Generation Z's interest in building wealth and financial literacy at an age when compounding investment returns are most powerful.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.